Loading company…
Reistone Biopharma develops medicines for immuno-inflammatory diseases.
Founded in 2018 and based in Shanghai, Reistone Biopharma develops treatments for immuno-inflammatory diseases, including SHR 0302 for inflammatory bowel and skin diseases. The company has offices in Beijing and the US and is running global multicenter clinical programs for oral and topical forms of the drug.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in